(Q40330295)

19 September 2017

1 reference

title

Mechanism of lesion production in pemphigus and pemphigoid (English)

1 reference

19 September 2017

1 reference

Sams WM Jr

1

1 reference

19 September 2017

Gammon WR

series ordinal

2

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 April 1982

1 reference

Journal of the American Academy of Dermatology

19 September 2017

1 reference

19 September 2017

6

1 reference

19 September 2017

4 Pt 1

1 reference

19 September 2017

431-452

1 reference

An electron microscopic study of acantholysis in pemphigus vulgaris

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

An Electron Microscopic Study on Pemphigus Vulgaris of the Mouth and the Skin with Special Reference to the Intercellular Cement*

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

"Bound" complement in the epidermis of patients with pemphigus vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Correlation of pemphigoid and pemphigus antibody titres with activity of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The Correlation between the Antibody Titers in Sera of Patients with Pemphigus Vulgaris and their Clincial State

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus antibodies: their role in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus antibody action on skin explants: kinetics of acantholytic changes and stability of antigens in tissue cultures of normal monkey skin explants

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Effect of Pemphigus Antibodies on Desmosomal Structure In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigoid and pemphigus antigens in cultured epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Identification of the substance binding pemphigus antibody and concanavalin A in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Characterization of Pemphigus Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Isolation and Characterization of Antigens Reactive with Pemphigus Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Partial Purification of Pemphigus-related Epidermal Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Detection of pemphigoid antigen, pemphigus antigen, and keratin filaments by indirect immunofluorescence in cultured human epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Negative complement immunofluorescence in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Direct immunofluorescent study of the skin on occurrence of complement in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Classical and alternate pathway activation of complement in pemphigus vulgaris lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Capability of complement fixation of pemphigus antibodies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Complement-Fixing Pemphigus Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Complement activation in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Characterization of cryoprecipitates in pemphigus: demonstration of pemphigus antibody activity in cryoprecipitates using the immunofluorescent technique

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Myasthenia gravis (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Studies in bullous diseases. Immunofluorescent serologic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Autoimmunity in Concurrent Myasthenia Gravis and Pemphigus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus vulgaris and myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Coexistence of peculiar pemphigus, myasthenia gravis and malignant thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Immunologic studies of a case of myasthenia gravis associated with pemphigus vulgaris after thymomectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

THYMOMA ASSOCIATED WITH ERYTHROID APLASIA, BULLOUS SKIN ERUPTION, AND THE LUPUS ERYTHEMATOSUS CELL PHENOMENON; REPORT OF A CASE

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The "pemphigus" antibody and immunopathies affecting the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Occurrence of malignancy in immunodeficiency diseases. A literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus vulgaris and internal malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Hodgkin's disease and pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus vulgaris following D-penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus in a Patient Treated With Penicillamine for Generalized Morphea

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Penicillamine pemphigus and the nephrotic syndrome occurring simultaneously

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Captopril-induced pemphigus.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Immunohistochemistry of Ultraviolet-Induced Pemphigus and Pemphigoid Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus antibody interaction with human epidermal cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigus acantholysis: a unique immunological injury

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Proteinase activation: a mechanism for cellular dyshesion in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Myasthenic immunoglobulin accelerates acetylcholine receptor degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Morphologic and Functional Evidence for Release of Mast-Cell Products in Bullous Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The dermo-epidermal junction in bullous pemphigoid. An electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Electron Microscopic Study of Bullous Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Formation and origin of basal lamina and anchoring fibrils in adult human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Basement zone antibodies in bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Ultrastructural Localization Of Immunoglobulins in Bullous Pemphigoid Skin. Employment of a New Peroxidase-Antiperoxidase Multistep Method

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Coexistence of Bullous Pemphigoid and Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Detection of antibodies after immune complex splitting in serum of patients with bullous pemphigoid and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The complement system in bullous pemphigoid. VI. C3 fixing activity in the absence of detectable antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Cutaneous Immunopathology: Recent Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Complement activation in bullous skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The complement system in pemphigus, bullous pemphigoid and herpes gestationis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Bullous pemphigoid antigen synthesized in vitro by human epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Demonstration of the Complement Regulating Protein, β1H, in Skin Biopsies from Patients with Bullous Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Ultrastructural Localization Of In Vivo-Bound Complement In Bullous Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970036-2

7 January 2021

10.1016/S0190-9622(82)70036-2

Identifiers

DOI

0 references

1 reference